Different chromosomal imbalances in metastasized and nonmetastasized tongue carcinomas identified by comparative genomic hybridization

Oral Oncology

Volumn 40, Issue 4, 2004, Pages 364-371

  Hannen, Egied J M ^a,b   Macville, Merryn V E ^a,d   Wienk, Sandra M ^a   Slootweg, Pieter J ^c   Manni, Johannes J ^d   Hanselaar, Antonius G J M ^a   De Wilde, Peter C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Comparative genomic hybridization; Head and neck neoplasms; Human genome; Metastasis; Tongue neoplasms

Indexed keywords

ARTICLE; CHROMOSOME; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; GENOMICS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; TONGUE CARCINOMA;

EID: 1242292970     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2003.09.011     Document Type: Article

References (39)

1. el-Naggar A.K., Hurr K., Batsakis J.G., Luna M.A., Goepfert H., Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 55:1995;2656-2659.
2. Califano J., van der Riet P., Westra W.et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56:1996;2488-2492.
3. Califano J., Westra W.H., Meininger G., Corio R., Koch W.M., Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin. Cancer Res. 6:2000;347-352.
4. Bockmuhl U., Schwendel A., Dietel M., Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res. 56:1996;5325-5329.
5. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN) 1: carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 36:2000;256-263.
6. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol. 36:2000;311-327.
7. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol. 36:2000;404-413.
8. Bockmuhl U., Petersen S., Schmidt S.et al. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res. 57:1997;5213-5216.
9. Kurokawa H., Yamashita Y., Takeda S., Zhang M., Fukuyama H., Takahashi T. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck. 24:2002;731-736.
10. Yuen A.P., Lam K.Y., Wei W.I.et al. A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am. J. Surg. 180:2000;139-143.
11. Hannen E.J., van der Laak J.A., Manni J.J.et al. An image analysis study on nuclear morphology in metastasized and non-metastasized squamous cell carcinomas of the tongue. J. Pathol. 185:1998;175-183.
12. Kallioniemi A., Kallioniemi O.P., Sudar D.et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
13. Jeuken J.W., Sprenger S.H., Wesseling P.et al. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J. Neuropathol. Exp. Neurol. 58:1999;606-612.
14. Du Manoir S., Kallioniemi O.P., Lichter P.et al. Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry. 19:1995;4-9.
15. Van Oijen M.G., Slootweg P.J. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol. Biomarkers Prev. 9:2000;249-256.
16. Speicher M.R., Howe C., Crotty P., du Manoir S., Costa J., Ward D.C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res. 55:1995;1010-1013.
17. Heselmeyer K., Macville M., Schröck E.et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer. 19:1997;233-240.
18. Mao L., el-Naggar A.K., Fan Y.H.et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 56:1996;5600-5604.
19. Redon R., Muller D., Caulee K., Wanherdrick K., Abecassis J., Du Manoir S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res. 61:2001;4122-4129.
20. Redon R., Hussenet T., Bour G.et al. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer. Cancer Res. 62:2002;6211-6217.
21. Shayesteh L., Lu Y., Kuo W.L.et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 21:1999;99-102.
22. Pershouse M.A., El-Naggar A.K., Hurr K., Lin H., Yung W.K., Steck P.A. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene. 14:1997;369-373.
23. Wolff E., Girod S., Liehr T.et al. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation. Oral Oncol. 34:1998;186-190.
24. Buchhagen D.L., Worsham M.J., Dyke D.L., Carey T.E. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis. Head Neck. 18:1996;529-537.
25. Bockmuhl U., Ishwad C.S., Ferrell R.E., Gollin S.M. Association of 8p23 deletions with poor survival in head and neck cancer. Otolaryngol. Head Neck Surg. 124:2001;451-455.
26. el-Naggar A.K., Hurr K., Luna M.A., Goepfert H., Hong W.K., Batsakis J.G. Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers. Diagn. Mol. Pathol. 6:1997;305-308.
27. Veltman J.A., van Weert I., Aubele M.et al. Specific steps in aneuploidization correlate with loss of heterozygosity of 9p21, 17p13 and 18q21 in the progression of pre-malignant laryngeal lesions. Int. J. Cancer. 91:2001;193-199.
28. Jin Y.S., Higashi K., Mandahl N.et al. Frequent rearrangement of chromosomal bands 1p22 and 11q13 in squamous cell carcinomas of the head and neck. Genes Chromosomes Cancer. 2:1990;198-204.
29. VanDyke D.L., Worsham M.J., Benninger M.S.et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer. 9:1994;192-206.
30. Akervall J.A., Jin Y., Wennerberg J.P.et al. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer. 76:1995;853-859.
31. el-Naggar A.K., Steck K., Batsakis J.G. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry. 21:1995;47-51.
32. Roh H.J., Shin D.M., Lee J.S.et al. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res. 60:2000;6496-6502.
33. Jin Y., Hoglund M., Jin C.et al. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer. 22:1998;312-320.
34. Cowan J.M., Beckett M.A., Weichselbaum R.R. Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines. Cancer Res. 53:1993;5542-5547.
35. Soder A.I., Hopman A.H., Ramaekers F.C., Conradt C., Bosch F.X. Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck. Cancer Res. 55:1995;5030-5037.
36. Resto V.A., Caballero O.L., Buta M.R.et al. A putative oncogenic role for MPP11 in head and neck squamous cell cancer. Cancer Res. 60:2000;5529-5535.
37. Cortesina G., Martone T., Galeazzi E.et al. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int. J. Cancer. 89:2000;286-292.
38. Ramirez R., Hsu D., Patel A.et al. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (c-MET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin. Endocrinol. (Oxf). 53:2000;635-644.
39. Xiao G.H., Jeffers M., Bellacosa A., Mitsuuchi Y., Van de Woude G.F., Testa J.R. Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. USA. 98:2001;247-252.